Globomedica

Egg, Switzerland Founded: 2009 • Age: 17 yrs Acquired By The Biomedica
Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland.
Request Access

About Globomedica

Globomedica is a company based in Egg (Switzerland) founded in 2009 was acquired by The Biomedica in March 2016.. Globomedica offers products and services including Pharmacare and Spezialapotheke. Globomedica operates in a competitive market with competitors including AmerisourceBergen, Xantis Pharma, DCS Pharma, RUWAG and Akenco Pharma, among others.

  • Headquarter Egg, Switzerland
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Globomedica Ag
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    The Biomedica

    (Mar 01, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Globomedica

Globomedica offers a comprehensive portfolio of products and services, including Pharmacare and Spezialapotheke. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Tailored solutions for pharmaceutical product distribution

Direct shipment of medications for special therapy areas

Funding Insights of Globomedica

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Globomedica

Globomedica has secured backing from 1 investor. Prominent investors backing the company include The Biomedica. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
The Biomedica is engaged in publishing open access scientific journals.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Globomedica

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Globomedica

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Globomedica Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Globomedica

Globomedica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Xantis Pharma, DCS Pharma, RUWAG and Akenco Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical distribution and supply chain services are provided globally.
domain founded_year HQ Location
Distributor of generic prescription and over-the-counter products
domain founded_year HQ Location
Pharmaceutical products are distributed by DCS Pharma in Switzerland.
domain founded_year HQ Location
Distributor of drugs
domain founded_year HQ Location
Serves as a diversified distributor in the healthcare sector.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Globomedica

Frequently Asked Questions about Globomedica

When was Globomedica founded?

Globomedica was founded in 2009.

Where is Globomedica located?

Globomedica is headquartered in Egg, Switzerland. It is registered at Egg, Zurich, Switzerland.

What does Globomedica do?

Globomedica was established in 2009 and is based in Egg, Switzerland. Operations focus on the distribution of diversified pharmaceutical products within the healthcare sector. The company is led by Managing Director Peter T Vetterli. Services are facilitated through the online domain globomedica.ch, supporting logistics and supply chain needs for various drug categories in the region.

Who are the top competitors of Globomedica?

Globomedica's top competitors include AmerisourceBergen, DCS Pharma and RUWAG.

What products or services does Globomedica offer?

Globomedica offers Pharmacare and Spezialapotheke.

Who are Globomedica's investors?

Globomedica has 1 investor. Key investors include The Biomedica.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available